Aris Global

Aris Global, founded in 1987, is a prominent provider of cloud-based software solutions tailored for the life sciences and healthcare sectors. The company specializes in end-to-end technology platforms that support critical functions such as clinical development, pharmacovigilance, drug safety, and regulatory publishing. By delivering multi-tenant, automated software, Aris Global enables healthcare organizations to streamline complex drug development processes and ensure compliance with global regulatory standards.

Operating with a workforce of 1,000-5,000 employees, the company maintains a robust global footprint across 11 locations. This scale allows Aris Global to provide comprehensive support for medical affairs and pharmacological research on a worldwide basis. Meet Aris Global's team to gain insights into the leadership and organizational structure driving these technical operations. The firm’s commitment to innovation is reflected in its suite of industry-leading software, which is designed to meet the evolving needs of modern pharmaceutical and medical device companies.

In a competitive landscape, Aris Global differentiates itself through its specialized focus on life science technology and integrated cloud platforms. With annual revenue reaching $448.7M, the company competes with major industry players such as Veeva, Parexel, and Certara, leveraging its long-standing expertise to maintain a strong market position. By prioritizing high-performance, scalable software, the firm continues to advance the efficiency of drug safety and clinical trial management. Aris Global remains a preferred partner for organizations seeking to optimize their research and development workflows through advanced, next-generation technology.